Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

<p><strong>BACKGROUND:</strong><em>Plasmodium vivax</em> malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for <em>P. vivax</em>, has been reported in the country and has potential to undermine...

Полное описание

Библиографические подробности
Главные авторы: Htun, M, Mon, N, Aye, K, Hlaing, C, Kyaw, M, Handayuni, I, Trimarsanto, H, Bustos, D, Ringwald, P, Price, R, Auburn, S, Thriemer, K
Формат: Journal article
Язык:English
Опубликовано: BioMed Central 2017

Схожие документы